Statistics for Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
Total visits
| views | |
|---|---|
| Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study | 67 |
Total visits per month
| views | |
|---|---|
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 1 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:02cf0c71-3086-472a-ba62-606ead6f3baf | 59 |
| fendo-12-662865.pdf | 30 |
| java.util.UUID:c696a680-3ed8-4bb5-8022-929b7e9e39f7 | 11 |
| java.util.UUID:99d4594e-c6fb-40dc-80e3-8e5876cf3823 | 6 |
Top country views
| views | |
|---|---|
| United States | 51 |
| Sweden | 3 |
| India | 2 |
| South Korea | 1 |
| Malaysia | 1 |
| Russia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 41 |
| Lake Mary | 3 |
| Malmö | 3 |
| San Francisco | 3 |
| Ann Arbor | 1 |
| Bengaluru | 1 |
| Cambridge | 1 |
| Delhi | 1 |
| Kemerovo | 1 |
| Kuala Lumpur | 1 |
| Washington | 1 |